
Pharma Pulse 1/3/25: Physician Engagement and Tackling Health-Related Social Needs, Can Pain Be Patched Up? & more
The latest news for pharma industry insiders.
Is this level of involvement with health-related social needs associated with higher burnout?
A systematic review and meta-analysis found some supporting evidence for transdermal anti-inflammatory patches, but the results might be described as, well, patchy.
The rural region is changing fast as electricians from around the country plug the tech industry’s new, giant data centers into its ample power supply.
McKesson Corporation reported that on December 30, 2024 it has closed the transaction announced in September 2024 to sell its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, a Canadian private equity firm. This transaction enables the Company to focus capital deployment and prioritize investments expanding its strategic oncology and biopharma growth platforms.
Towards the end of 2024 I had the pleasure of speaking with Lawrence Werlin, MD, FACOG of HRC Fertility (you likely know him as @md.lawrence.werlin on TikTok). In his 
Links to individual parts below:
Navigating Fertility Misinformation on Social Media
The Ethical Implications of Sharing Personal & Professional Experiences on Social Media
Non-Surgical Approaches to Diagnosing Endometriosis
Leveraging Technology and Data for Personalized Fertility Treatment
Beyond IVF: The Next Generation of Fertility Solutions
The Fight for Reproductive Rights & Affordable Fertility Treatment
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor 
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

